Glenmark accused of conspiring to fix prices for generic drugs in US
The charge alleges that the gain to the conspirators, and the loss to the victims, was at least USD 200 million, it added.;
Advertisement
New Delhi: Glenmark Pharmaceuticals Inc, USA, was charged for conspiring to fix prices for generic drugs, the US Department of Justice said on Tuesday.
The case, filed in the US District Court in Philadelphia, Pennsylvania, involved allegation that Glenmark conspired with Apotex Corp and other generic drug companies to increase and maintain prices of pravastatin and other generic drugs beginning in or around May 2013 and continuing until at least in or around December 2015, the Department of Justice said in a statement.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.